The risk of hemophagocytic lymphohistiocytosis in Hermansky

[1]  S. Ehl,et al.  Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. , 2013, Blood.

[2]  T. Blackwell,et al.  The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. , 2012, American journal of respiratory and critical care medicine.

[3]  Sebastian F N Bode,et al.  Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis , 2012, Arthritis Research & Therapy.

[4]  A. Iwasaki,et al.  Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells. , 2012, Immunity.

[5]  S. Ehl,et al.  A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. , 2012, Blood.

[6]  W. Gahl,et al.  Interstitial Lung Disease and Pulmonary Fibrosis in Hermansky-Pudlak Syndrome Type 2, an Adaptor Protein-3 Complex Disease , 2012, Molecular medicine.

[7]  H. Ljunggren,et al.  Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. , 2011, Blood.

[8]  J. Meller,et al.  Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. , 2011, Blood.

[9]  K. Schwarz,et al.  Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. , 2011, Blood.

[10]  A. Filipovich,et al.  How I treat hemophagocytic lymphohistiocytosis. , 2011, Blood.

[11]  E. Spector,et al.  Novel mutation causing Hermansky–Pudlak Syndrome Type 2 , 2010, Pediatric blood & cancer.

[12]  B. Beutler,et al.  Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells , 2010, Proceedings of the National Academy of Sciences.

[13]  A. Iwasaki,et al.  Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3 , 2010, Science.

[14]  A. Mumford,et al.  Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1 , 2010, Haematologica.

[15]  A. Fischer,et al.  Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. , 2009, Blood.

[16]  A. Fischer,et al.  A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH) , 2008, European journal of immunology.

[17]  R. Badolato,et al.  Novel insights from adaptor protein 3 complex deficiency. , 2007, The Journal of allergy and clinical immunology.

[18]  A. Fischer,et al.  Genetic defects affecting lymphocyte cytotoxicity. , 2007, Current opinion in immunology.

[19]  B. Beutler,et al.  Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis , 2007, The Journal of Experimental Medicine.

[20]  J. Kurtzberg,et al.  Hematopoietic cell transplantation for Chediak–Higashi syndrome , 2007, Bone Marrow Transplantation.

[21]  P. Gulleman,et al.  Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. , 2007, American journal of respiratory cell and molecular biology.

[22]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[23]  U. Pannicke,et al.  Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. , 2006, Blood.

[24]  A. Schäffer,et al.  Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. , 2006, Blood.

[25]  L. Notarangelo,et al.  Innate immunity defects in Hermansky-Pudlak type 2 syndrome. , 2006, Blood.

[26]  R. Gibbons,et al.  Lung-Restricted Macrophage Activation in the Pearl Mouse Model of Hermansky-Pudlak Syndrome1 , 2006, The Journal of Immunology.

[27]  C. Marsh,et al.  Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. , 2005, Blood.

[28]  E. Clark,et al.  Mutations in mice that influence natural killer (NK) cell activity , 1981, Immunogenetics.

[29]  P. Marrack,et al.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. , 2004, Blood.

[30]  R. Swank,et al.  Murine Hermansky–Pudlak syndrome genes: regulators of lysosome‐related organelles , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[31]  N. Nagarajan,et al.  The Adaptor Protein AP-3 Is Required for CD1d-Mediated Antigen Presentation of Glycosphingolipids and Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.

[32]  T. Hamblin,et al.  Adaptor protein 3–dependent microtubule-mediated movement of lytic granules to the immunological synapse , 2003, Nature Immunology.

[33]  G. Besra,et al.  Lysosomal Localization of Murine CD1d Mediated by AP-3 Is Necessary for NK T Cell Development 1 , 2003, The Journal of Immunology.

[34]  G. Griffiths,et al.  Lytic granules, secretory lysosomes and disease. , 2003, Current opinion in immunology.

[35]  G. Acland,et al.  Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase , 2003, Nature Genetics.

[36]  James J. Lee,et al.  Pulmonary pathologies in pallid mice result from nonhematopoietic defects. , 2002, Experimental and molecular pathology.

[37]  J. Bonifacino,et al.  Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. , 2002, Immunity.

[38]  W. Gahl,et al.  Nonsense Mutations in ADTB3A Cause Complete Deficiency of the β3A Subunit of Adaptor Complex-3 and Severe Hermansky-Pudlak Syndrome Type 2 , 2002, Pediatric Research.

[39]  Rachel Rudge,et al.  Assembly and function of AP-3 complexes in cells expressing mutant subunits , 2002, The Journal of cell biology.

[40]  J. Bonifacino,et al.  A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. , 2000, The American journal of medicine.

[41]  R. Elliott,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Abnormal Expression and Subcellular Distribution of Subunit Proteins of the AP-3 Adaptor Complex Lead to Platelet Storage Pool Deficiency in the Pearl Mouse , 2022 .

[42]  A. Seymour,et al.  The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. , 1999, Human molecular genetics.

[43]  R. Zinkernagel,et al.  Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus , 1998, The Journal of experimental medicine.

[44]  P. Klenerman,et al.  A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro , 1997, European journal of immunology.

[45]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[46]  R M Zinkernagel,et al.  Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.

[47]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[48]  N. Mangini,et al.  Discrete visual defects in pearl mutant mice. , 1983, Science.

[49]  P. Pudlák,et al.  Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. , 1959, Blood.